Biosurgery Market – Detailed Analysis By Size, Status and Forecast 2026

The research report on “Global Biosurgery Market” covers the different market scenarios that have a direct impact on the growth of the market. The Global Biosurgery Market was valued at USD 12.2 billion in 2021 and is expected to reach USD 16.0 billion by 2026, expanding at a CAGR of 5.7% by the end of the forecast period. The study includes information on market factors such as the market dynamics, including drivers, restraints, challenges, threats, and the potential growth opportunities, market trends, development patterns, financial information (revenue), latest technologies, innovations, leading competitors, and regional analysis of the market. The market is expected to grow at a significate rate during the forecast period, owing to the demand from all corners of the globe.

In the first section, the report consists of the basic overview of the market, including product definitions, classifications, new product launches, key developments, and the industry chain structure of the overall market. Besides, the report covers intelligence of different segments such as the product type, technology, application, industry vertical, end-user, and geography. In the next section, the report focuses on the industry development policies, plans, production cost, value, volume, import/export, cost structures, supply and value chain analysis, manufacturing processes, and consumption figures. Furthermore, the report highlights the regional and segment-based aspects to access the untapped opportunities in the Global Biosurgery Market. The information is provided in the form of year-to-year evolution and basis point share, I term of CAGR and revenue.

Request a Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302

Browse 439 market data Tables and 52 Figures spread through 391 Pages and in-depth TOC on “Biosurgery Market by Product Type (Sealants, Hemostats, Adhesion Barrier, Soft Tissue Attachments, Biological Meshes, DBM, Bone Graft Substitutes), Application (Orthopedic, Cardiovascular), End User (Hospitals, Clinics) – Global Forecast to 2026

Prominent Players in Biosurgery Market are:

Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. , Pfizer Inc. , Cyrolife Inc. , Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), Smiths & Nephew Plc. (UK) and Among Others

Medtronic Plc (Ireland) held the second position in the global biosurgery market. Company has exhaustive product portfolio, specifically in bone graft substitutes and soft tissue attachment category. Additionally, the company leverages its research capabilities and innovative product portfolio to ensure a leading position in the biosurgery market.  In FY2020, the company invested USD 2,331 million in R&D, up from USD 2253 million in FY2018. Medtronic focuses on organic growth strategies such as innovation, product launch and approval for its growth in the biosurgery market, as evidenced by its recent product approval and launches during FY2018 to FY2019 across orthopedic and spine surgery portfolio.

Biosurgery Industry Insights:

Abbott Laboratories accounted for the largest share of the point-of-care molecular diagnostics market in 2020. The company’s leading position can be attributed to its strong sales and distribution network. The company invests a significant amount of its revenue in R&D. The company also adopts organic growth strategies such as product launches to increase its dominance in this market.

F. Hoffmann-La Roche Ltd. held the second position in the point-of-care molecular diagnostics market in 2020. The company’s leading position is attributed to its wi犀利士
de product portfolio. Under its flagship brand- cobas- the company offers a wide variety instruments and reagents that are widely used by end users across the globe. The company also has a wide geographic presence, spanning North America, Europe, the Middle East and Africa, and Asia. This enables the company to cater to customers across the globe.

COVID-19 Impact on Global Biosurgery Market:

Owing to the growing incidence of COVID-19, hospitals became high-risk zones, specifically for patients suffering from chronic conditions. As a result, non-critical procedures such as elective surgeries were either canceled or postponed during the first and second quarter of 2020, which resulted in a significant decline in the total number of elective surgical procedures performed. As a result, the demand for biosurgery products witnessed a sharp decline in 2020. The second wave of COVID-19 further deprioritized elective surgical procedures. Governments across the globe have also issued limitations and bans on medical procedures and elective surgeries. With the current pandemic scenario, surgical procedures have witnessed a decline and are only expected to increase in the third quarter of 2021 in countries such as the US. Some countries in the EU have resumed surgical interventions, which has increased the demand for biosurgery products in the region.

The surgical sealants and adhesives segment is expected to grow at the highest CAGR

Based on the product, the surgical sealants and adhesives segment accounted to be the fastest-growing segment in the global biosurgery market in 2020. Sealants and adhesives have successfully replaced traditional wound closure techniques, such as suturing or stapling, in many surgical applications. These products are becoming an increasingly important element in modern medicine by enabling innate wound healing processes to occur through the adhesion of tissue to the on-site or non-tissue surfaces. The high growth of surgical sealants and adhesives segment can be attributed to the growing adoption of natural/biological sealants such as fibrin-based sealants globally, owing to their relative safety and low risk of infection

The orthopedic segment accounted for the largest share of the biosurgery market, by application

Based on applications, the orthopedic segment commanded the largest share in 2020. Increasing incidence of sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), have surged the volume of orthopedic surgeries. Orthopedic surgical procedures are often associated with the risk of significant blood loss owing to the dissection of bony and fibrotic tissues. Thus, bleeding management and the effective regeneration of tissues and bones are the common challenges faced by orthopedic surgeons. In order to overcome these challenges, surgeons finds substantial use of surgical sealants, hemostats, bone-graft substitutes, and soft-tissue repair products, which is driving the revenue growth in the segment.

The study categorizes the biosurgery market based on product, application, end user, and regional and global level:

Global Biosurgery Market by Product

• Bone Graft Substitutes
  • Demineralized bone matrix
  • Synthetic Bone Grafts
  • Bone Morphogenetic Proteins
  • Other Bone-Graft Substitutes
• Soft-tissue attachments
  • Synthetic meshes
  • Biological meshes
    • Allografts
    • Xenografts
  • Hemostatic agents
    • Thrombin-based hemostatic agents
    • Oxidized regenerated cellulose-based hemostatic agents
    • Combination hemostatic agents
  • Surgical sealants and adhesives
    • Natural/Biological Sealants and Adhesives
      • Natural/Biological Sealants and Adhesives, By Type
        • Fibrin Sealants
        • Collagen-Based Sealants
        • Gelatin-Based Sealants
        • Albumin-Based Sealants
        • Other Natural/Biological Sealants
      • Natural/Biological Sealants and Adhesives, By Origin
        • Human Blood-Based Sealants and Adhesives
        • Animal-Based Sealants and Adhesives
      • Synthetic and Semi-Synthetic Sealants and Adhesives
        • Peg Hydrogels
        • Cyanoacrylate-Based Sealants and Adhesives
        • Urethane-Based Sealants and Adhesives
        • Other Synthetic and Semi-Synthetic Sealants and Adhesives
      • Adhesion Barriers
        • Synthetic Adhesion Barriers
          • Hyaluronic Acid-Based Adhesion Barriers
          • Regenerated Cellulose-Based Adhesion Barriers
          • Peg-Based Adhesion Barriers
          • Other Synthetic Adhesion Barriers
        • Natural Adhesion Barriers
          • Collagen & Protein Adhesion Barriers
          • Fibrin-Based Adhesion Barriers
        • Staple-Line Reinforcement Agents

by Application

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Urological Surgery
• Thoracic Surgery
• Others

Biosurgery Industry by End User

• Hospitals
• Clinics
• Others

The report covers exhaustive analysis on:

• Overview of the parent market
• Global Biosurgery Market Segments, Dynamics, Market Size, Share, Price, Volume, and Cost
• Historical, current, and projected market size in terms of volume and value
• Global Biosurgery Market Forecast 2021 to 2026
• Supply & Demand Value Chain
• Global Biosurgery Market dynamics, including the current trends / drivers / threats / restraints / challenges
• Potential and niche segments/regions exhibiting promising growth
• Market landscape, competition, and leading companies involved
• Strategies of leading companies and product offerings
• Technological advancements

About MarketsandMarkets™:

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Relate to Healthcare Industry Study:

• Home Healthcare Market: https://www.marketsandmarkets.com/Market-Reports/home-healthcare-equipment-market-696.html
• Optometry Equipment Market: https://www.marketsandmarkets.com/Market-Reports/optometry-eye-exam-equipment-market-14475790.html
• Medical Electrodes Market: https://www.marketsandmarkets.com/Market-Reports/medical-electrode-market-171260948.html
• Point of Care Molecular Diagnostics Market: https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html

Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland) and bioMérieux SA (France) are the Major Players in the Point of Care Molecular Diagnostics Market